Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02877706
What this trial is testing

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
University Hospital, Toulouse 1,500
Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Early research (Phase 1)Looking for participantsNCT07083960
What this trial is testing

OM336 in Autoimmune Cytopenias

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic AnemiaITP - Immune Thrombocytopenia
Lakefront Biotherapeutics West LLC 32
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Looking for participantsNCT07104565
What this trial is testing

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Who this might be right for
Immune Thrombocytopenia
Incyte Corporation 56
Not applicableLooking for participantsNCT04005638
What this trial is testing

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaAutoimmune Neutropenia
University Hospital, Bordeaux 200
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Post-approval studies (Phase 4)UnknownNCT03918265
What this trial is testing

Tacrolimus Treatment for Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune Hemolytic AnemiaPure Red Cell AplasiaEvans Syndrome
Peking Union Medical College Hospital 80
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)WithdrawnNCT04039477
What this trial is testing

Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Who this might be right for
Autoimmune Hemolytic AnemiaImmune Thrombocytopenia
Kezar Life Sciences, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07574073
What this trial is testing

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

Who this might be right for
Anti-CD20 Monoclonal AntibodyBTK InhibitorsImmune Thrombocytopenia (ITP)+1 more
Qi deng 30
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Testing effectiveness (Phase 2)Looking for participantsNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Not applicableStudy completedNCT04057703
What this trial is testing

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Who this might be right for
Immune Thrombocytopenic PurpuraAutoimmune Hemolytic AnemiaEvan Syndrome+1 more
University Hospital, Bordeaux 454
Early research (Phase 1)Study completedNCT06004947
What this trial is testing

A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Who this might be right for
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen 32
Not applicableLooking for participantsNCT05937828
What this trial is testing

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome
University Hospital, Bordeaux 3,500
Large-scale testing (Phase 3)Study completedNCT00749112
What this trial is testing

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Who this might be right for
Idiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune
Hospital Universitario Dr. Jose E. Gonzalez 19
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Next Page